Background: Because infection has been associated with the development of bronchiolitis obliterans syndrome (BOS), we hypothesized that post-transplant hypogammaglobulinemia would be associated with infection and BOS. Methods: Cross-sectional levels of serum immunoglobulins were measured on 2 occasions in our transplant cohort and models developed to explain serum immunoglobulin levels and BOS-free survival. Results: A total of 139 patients (median age, 46.6 years) were evaluated at 47 months (range, 15-74 months) after transplant, and 87 were re-evaluated at 72 months (40-107 months). Of this cohort, 44% were immunoglobulin (Ig) G deficient and levels remained stable across the study period, and 27% were IgA deficient and levels fell sligh...
The main limitation for overall survival after lung transplantation (LTx) is the development of chro...
International audienceBACKGROUND: Chronic bronchiolitis obliterans syndrome (BOS) remains a major li...
Chronic lung allograft dysfunction (CLAD) is a limiting factor for long-term survival in lung transp...
WOS: 000268793800015PubMed ID: 19067916Infection is the leading cause of morbidity and mortality in ...
Bronchiolitis obliterans syndrome (BOS) is the main and late chronic complication after lung transpl...
AbstractObjective: A retrospective analysis was performed to examine the role of HLA antibodies and ...
Bronchiolitis obliterans syndrome (BOS) is a pulmonary complication of allogeneic hematopoietic cell...
Bronchiolitis obliterans syndrome (BOS) remains a major complication after lung transplantation, cau...
AbstractObjective: This study identifies specific clinical and immunologic factors in lung transplan...
Lung transplantation has evolved into a life-saving therapy for select patients with end-stage lung ...
The main limitation for overall survival after lung transplantation (LTx) is the development of chro...
International audienceBACKGROUND: Chronic bronchiolitis obliterans syndrome (BOS) remains a major li...
Chronic lung allograft dysfunction (CLAD) is a limiting factor for long-term survival in lung transp...
WOS: 000268793800015PubMed ID: 19067916Infection is the leading cause of morbidity and mortality in ...
Bronchiolitis obliterans syndrome (BOS) is the main and late chronic complication after lung transpl...
AbstractObjective: A retrospective analysis was performed to examine the role of HLA antibodies and ...
Bronchiolitis obliterans syndrome (BOS) is a pulmonary complication of allogeneic hematopoietic cell...
Bronchiolitis obliterans syndrome (BOS) remains a major complication after lung transplantation, cau...
AbstractObjective: This study identifies specific clinical and immunologic factors in lung transplan...
Lung transplantation has evolved into a life-saving therapy for select patients with end-stage lung ...
The main limitation for overall survival after lung transplantation (LTx) is the development of chro...
International audienceBACKGROUND: Chronic bronchiolitis obliterans syndrome (BOS) remains a major li...
Chronic lung allograft dysfunction (CLAD) is a limiting factor for long-term survival in lung transp...